DelSiTech Ltd

DelSiTech Ltd

Pharmaceutical Manufacturing

Turku, Southwest Finland 2 253 followers

The natural solution for drug delivery

About us

DelSiTech is a drug delivery and drug development company based in Turku, Finland. DelSiTech has developed a unique proprietary technology making it a world leader in advanced biodegradable silica-based drug delivery. The technology has successfully been applied to the controlled release of small molecules, biopharmaceuticals and viral vectors with a focus on parenteral and local administration. We can work with you from early feasibility testing to clinical proof of concept; the technology can also be licensed to industry partners. With the DelSiTechTMSilica Matrix, we can create novel products, provide alternative administration opportunities, and extend and manage the life cycle of existing products. More patient-friendly products can be developed which release active compounds over days to many months. The technology is also well suited for challenging drug delivery needs such as controlled local delivery to the eye or the brain. At DelSiTech, we are also developing our own in-house supergeneric drug products for significant unmet medical and market needs. Our lead product, 1308, is a 3 month subcutaneous product for hepatitis B. 1308 will enter clinical studies in Q1 2017.

Toimiala
Pharmaceutical Manufacturing
Yrityksen koko
11–50 työntekijää
Päätoimipaikka
Turku, Southwest Finland
Tyyppi
Privately Held
Perustettu
2001
Erityisosaaminen

Sijainnit

  • Ensisijainen

    Itäinen Pitkäkatu 4 c

    Turku, Southwest Finland 20520, FI

    Get directions

Työntekijät DelSiTech Ltd

Päivitykset

Samankaltaisia sivuja

Rahoitus

DelSiTech Ltd 3 Kierroksia yhteensä

Viimeinen kierros

Sarja tuntematon

10 878 564,00 $

Katso lisätietoja crunchbasesta